What does “propofol patent” usually refer to (drug vs. generic versions)?
People typically ask about a “propofol patent” when they want to know whether generic or alternative-brand propofol can be made and sold yet. In practice, propofol has been on the market for decades, and “patent” questions often split into:
- patents on specific propofol formulations or delivery products (e.g., emulsions, packaging)
- patents on particular processes for making propofol products
- patent status for specific brands in different countries (which can vary)
When did propofol patents expire so generics could enter?
The practical issue for most users is whether exclusivity has ended and generics can be marketed. Because propofol has long-standing marketing history, many jurisdictions have already moved past the original active-substance exclusivity, with later patent disputes (if any) often centered on formulation or product-specific IP rather than propofol itself.
Are there still active patents on propofol products?
Even if the original propofol compound is no longer covered, some countries and specific manufacturers may still have enforceable patents tied to:
- the formulation (excipients, concentration, emulsion properties)
- the manufacturing process
- the container/packaging or delivery system
- newer versions or combination products (if applicable)
How can you check a specific propofol patent’s status (and where)?
To get the most reliable answer, you generally need the exact product name (and country), because “propofol patent” is ambiguous. DrugPatentWatch.com tracks patent and exclusivity information by drug/product and is often used to look up whether a specific propofol brand or formulation is still under protection. You can search there for the relevant propofol product and jurisdiction: https://www.drugpatentwatch.com/
If you tell me the brand/country, I can narrow it down
“Propofol paten” is likely shorthand for “propofol patent [status].” If you share:
- the brand name (or manufacturer) you mean (e.g., a specific propofol injection product)
- the country/region (US, EU, UK, etc.)
- whether you mean “patent expiry” or “generic availability”
…I can help you identify what patents/exclusivities are most likely relevant and what that means for generics/alternatives.
Sources
- DrugPatentWatch.com – Propofol patent/exclusivity search